Access More Opportunity

Powered by AAM, Women in Health Policy (WiHP) is a nonpartisan network that aims to increase the number of women guiding our nation’s health care and to amplify their effectiveness and professional advancement.

Join Now
Approve the CMS Rule

America’s patients are needlessly spending too much out-of-pocket for affordable generics. CMS can lower costs by 4 billion dollars a year by placing generics on the generics tier.

Learn More
Prescription for Savings

Congress can take meaningful action to lower prescription drug costs for patients who rely on affordable medicines to live healthy lives.

Learn More
State-by-State Savings

To view a full break down of generic savings by state and payer type, view our interactive U.S. map.

View Map
Generic Drugs are the Prescription for Savings

More than 9 out of 10 generic drug prescriptions are filled for $20 or less.

View Infographic
Preserve Patient Access in Trade Agreements

The new trade agreement (USMCA) keeps drug prices high, for longer and creates new barriers to competition from generics and biosimilars. Without action, drug prices will remain out of reach for Americans.

Learn More

Working to leave a positive impact on...

Industry

We promote competition in the pharmaceutical industry by lowering barriers to entry for manufacturers and combatting anti-competitive abuses by some brand drug companies who put profits before patients. Learn More

People

We measure our success as an industry by the lives we impact. We work to protect the low cost of current drugs and to drive down the cost of developing new ones, expanding access to as many people as possible. Learn More

Society

We are a trusted partner and established authority within the pharmaceutical field. We provide accurate, timely data to educate policymakers and promote general public knowledge regarding the positive impact of affordable medicines. Learn More

About Us

The Association for Accessible Medicines, formerly the Generic Pharmaceutical Association, improves access to safe, quality, effective medicine. Better access to medicine is relevant to everybody because, after all, we’re all patients at some point.

Health is the foundation for everything in life. Healthy people are better able to reach their full potential. Generics and biosimilars help more people in more places live healthier and longer.

Recent Updates

Feb 26, 2019 | Erica Klinger

Rich’s Generic Story: No Sweat

Jonathan Kimball Joins AAM as Vice President, Trade & International Affairs

Feb 25, 2019 | Rachel Schwartz

Jonathan Kimball Joins AAM as Vice President, Trade and International Affairs

HHS Proposal Will Help America’s Patients Realize the Full Value of Their Generics and Biosimilars

Feb 20, 2019 | Craig Burton

HHS Proposal Will Help America’s Patients Realize the Full Value of Their Generics and Biosimilars

Patient Victory: Supreme Court Denies Review of Drug Pricing Law HB 631

Feb 19, 2019 | Rachel Schwartz

Patient Victory: Supreme Court Denies Review of Drug Pricing Law HB 631

AAM President and CEO Chip Davis

Feb 15, 2019 | Rachel Schwartz

Access! New Orleans Style: An Industry Steps Up

AAM Welcomes the Re-introduction of the PACED Act

Feb 13, 2019 | Rachel Schwartz

AAM Welcomes Re-Introduction of the PACED Act